Tacrolimus powder

Tacrolimus powder

Tacrolimus powder

Min.Order / FOB Price:Get Latest Price

100 Gram

FOB Price: USD 88.0000

  • Min.Order :100 Gram
  • Purity: 99.6%
  • Payment Terms : T/T,,MoneyGram,Other

Keywords

Tacrolimus Tacrolimus powder 104987-11-3

Quick Details

  • Appearance:White crystals or crystalline powder
  • Application:PRODUCT DESCRIPTION Tacrolimus (fujimycin) was discovered as a potent inhibitor of IL2 production in a targeted search for novel immunosuppressants. Tacrolimus acts by blocking T cell proliferation i
  • PackAge:1g ,5g ,10g,50g,100g,1kg by plastic bag and aluminum foil bag . or at customer's requirements
  • ProductionCapacity:100|Kilogram|Month
  • Storage:Cool, dry, dark in closed containers; recommended limit 2 years.
  • Transportation:normal temperature

Superiority:

Trade Assurance
Get full protection for your orders

100% Product quality protection
100% On-time shipment protection
100% Payment protection

 

Details:

Tacrolimus  powder

Tacrolimus(also FK-506) is an immunosuppressive drug that is mainly used after allogeneic organ transplant to reduce the activity of the patient's immune system and so lower the risk of organ rejection.

 

【Product Name】Tacrolimus  
【CAS No.】104987-11-3
【Molecular Formular】C44H69NO12 
【Molecular Weight】804.02
【Assay】99.0% 
【Appearance】White crystalline powder
【Standard】Medical grade
【Packing】25kg/drum or at customer's request.
【Storage】Tight container, protect from light

 

PRODUCT DESCRIPTION

Tacrolimus (fujimycin) was discovered as a potent inhibitor of IL2 production in a targeted search for novel immunosuppressants. Tacrolimus acts by blocking T cell proliferation in vitro by inhibiting the generation of several lymphokines, notably the original target IL-2. Tacrolimus inhibits the activity of FK-506 binding protein, Ca2+-dependent phosphatase and calcineurin, and activates NF-κB through phosphorylation and degradation of IκBα

 

APPLICATIONS/USAGE

An immunosuppressant that blocks T cell proliferation in vitro by inhibiting the generation of several lymphokines, especially IL-2. Shown to inhibit the activity of FK-506 binding protein, thereby reversing its effects on sarcoplasmic reticulum Ca+2 release. 2.FK-506 (Tacrolimus) is a macrolide immunosuppressive drug that is mainly used after allogeneic organ transplant to reduce the activity of the patient's immune system 3.For use after allogenic organ transplant to reduce the activity of the patient's immune system and so the risk of organ rejection. It was first approved by the FDA in 1994 for use in liver transplantation, this has been extended to include kidney, heart.

 

We have the following advantages and service

1.A novel R&D center with advanced ventilation equipments and modern experiment equipments.

2.Two Large production factories with high capacity and meet the requirements of GMP.

3.Two warehouses in Shanghai China and Colorado USA.

4.Supplying the products from our manufacturers;

5.Custom synthesis of new products;

6.Help sourcing products and suppliers in China;

7.Assist the export and related affairs.

8.Stable quality,professional production & technology;

9.The most competitive price;

10.Steady supply, rapid delivery;

11.Perfect service, honest cooperation.

Related Searches

Confirm to collect the product to my collection?

OKCancel

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View